An Open-label, Single and Multiple Application of Intranasal Testosterone Gel (TBS-2) in Healthy Premenopausal Female Subjects at Three Dose Levels.
Phase of Trial: Phase I
Latest Information Update: 16 Oct 2017
At a glance
- Drugs Testosterone (Primary)
- Indications Female sexual dysfunction
- Focus Pharmacokinetics
- Sponsors Acerus Pharmaceuticals
- 13 Jun 2012 NCT reports actual end date is (Feb 2012).
- 21 Mar 2012 Status changed from active, no longer recruiting to completed, according to a Trimel Pharmaceuticals Corporation media release.
- 21 Mar 2012 Results published in a Trimel Pharmaceuticals Corporation media release.